197 related articles for article (PubMed ID: 34109508)
21. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
[TBL] [Abstract][Full Text] [Related]
22. Profiling of Cxcl12 receptors, Cxcr4 and Cxcr7 in murine testis development and a spermatogenic depletion model indicates a role for Cxcr7 in controlling Cxcl12 activity.
Westernströer B; Terwort N; Ehmcke J; Wistuba J; Schlatt S; Neuhaus N
PLoS One; 2014; 9(12):e112598. PubMed ID: 25460567
[TBL] [Abstract][Full Text] [Related]
23. CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
Goto M; Yoshida T; Yamamoto Y; Furukita Y; Inoue S; Fujiwara S; Kawakita N; Nishino T; Minato T; Yuasa Y; Yamai H; Takechi H; Seike J; Bando Y; Tangoku A
Ann Surg Oncol; 2017 Mar; 24(3):832-840. PubMed ID: 26577115
[TBL] [Abstract][Full Text] [Related]
24. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
[TBL] [Abstract][Full Text] [Related]
25. CXCR7 controls competition for recruitment of β-arrestin 2 in cells expressing both CXCR4 and CXCR7.
Coggins NL; Trakimas D; Chang SL; Ehrlich A; Ray P; Luker KE; Linderman JJ; Luker GD
PLoS One; 2014; 9(6):e98328. PubMed ID: 24896823
[TBL] [Abstract][Full Text] [Related]
26. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
[TBL] [Abstract][Full Text] [Related]
27. Exploring the CXCR4/CXCR7/CXCL12 Axis in Primary Desmoid Tumors.
Baccalini EA; Renne SL; Colombo P; Pasqualini F; Quagliuolo VL; Cananzi FCM; Grizzi F; Borroni EM
Anticancer Agents Med Chem; 2023; 23(20):2248-2253. PubMed ID: 36748819
[TBL] [Abstract][Full Text] [Related]
28. Relevance of the CXCR4/CXCR7-CXCL12 axis and its effect in pathophysiological conditions.
Huynh C; Dingemanse J; Meyer Zu Schwabedissen HE; Sidharta PN
Pharmacol Res; 2020 Nov; 161():105092. PubMed ID: 32758634
[TBL] [Abstract][Full Text] [Related]
29. Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions.
Desnoyer A; Dupin N; Assoumou L; Carlotti A; Gaudin F; Deback C; Peytavin G; Marcelin AG; Boué F; Balabanian K; Pourcher V;
Br J Dermatol; 2016 Dec; 175(6):1251-1262. PubMed ID: 27177037
[TBL] [Abstract][Full Text] [Related]
30. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
[TBL] [Abstract][Full Text] [Related]
31. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
32. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
Costantini S; Raucci R; De Vero T; Castello G; Colonna G
Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
[TBL] [Abstract][Full Text] [Related]
33. A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.
D'Alterio C; Avallone A; Tatangelo F; Delrio P; Pecori B; Cella L; Pelella A; D'Armiento FP; Carlomagno C; Bianco F; Silvestro L; Pacelli R; Napolitano M; Iaffaioli RV; Scala S
Int J Cancer; 2014 Jul; 135(2):379-90. PubMed ID: 24375277
[TBL] [Abstract][Full Text] [Related]
34. Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory bowel disease.
Werner L; Guzner-Gur H; Dotan I
Theranostics; 2013; 3(1):40-6. PubMed ID: 23382785
[TBL] [Abstract][Full Text] [Related]
35. Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells.
Liu C; Pham K; Luo D; Reynolds BA; Hothi P; Foltz G; Harrison JK
PLoS One; 2013; 8(3):e59750. PubMed ID: 23555768
[TBL] [Abstract][Full Text] [Related]
36. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
[TBL] [Abstract][Full Text] [Related]
37. CXC chemokine receptor 7 (CXCR7) regulates CXCR4 protein expression and capillary tuft development in mouse kidney.
Haege S; Einer C; Thiele S; Mueller W; Nietzsche S; Lupp A; Mackay F; Schulz S; Stumm R
PLoS One; 2012; 7(8):e42814. PubMed ID: 22880115
[TBL] [Abstract][Full Text] [Related]
38. CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients.
Schrevel M; Karim R; ter Haar NT; van der Burg SH; Trimbos JB; Fleuren GJ; Gorter A; Jordanova ES
Br J Cancer; 2012 Apr; 106(9):1520-5. PubMed ID: 22531719
[TBL] [Abstract][Full Text] [Related]
39. Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis.
Wang L; Wang L; Yang B; Yang Q; Qiao S; Wang Y; Sun Y
Clin Exp Metastasis; 2009; 26(8):1049-54. PubMed ID: 19859817
[TBL] [Abstract][Full Text] [Related]
40. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.
Levoye A; Balabanian K; Baleux F; Bachelerie F; Lagane B
Blood; 2009 Jun; 113(24):6085-93. PubMed ID: 19380869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]